BioMed Research International

BioMed Research International / 2014 / Article
Special Issue

Cell Death in Human Health and Disease

View this Special Issue

Research Article | Open Access

Volume 2014 |Article ID 935719 | 8 pages |

Predicting the Types of J-Proteins Using Clustered Amino Acids

Academic Editor: Dong Wang
Received24 Jan 2014
Revised04 Mar 2014
Accepted13 Mar 2014
Published02 Apr 2014


J-proteins are molecular chaperones and present in a wide variety of organisms from prokaryote to eukaryote. Based on their domain organizations, J-proteins can be classified into 4 types, that is, Type I, Type II, Type III, and Type IV. Different types of J-proteins play distinct roles in influencing cancer properties and cell death. Thus, reliably annotating the types of J-proteins is essential to better understand their molecular functions. In the present work, a support vector machine based method was developed to identify the types of J-proteins using the tripeptide composition of reduced amino acid alphabet. In the jackknife cross-validation, the maximum overall accuracy of 94% was achieved on a stringent benchmark dataset. We also analyzed the amino acid compositions by using analysis of variance and found the distinct distributions of amino acids in each family of the J-proteins. To enhance the value of the practical applications of the proposed model, an online web server was developed and can be freely accessed.

1. Introduction

J-protein, also known as Hsp40 (heat shock protein 40 kD), is a molecular chaperone protein and is found ubiquitously in both prokaryotes and eukaryotes [1, 2]. J-proteins represent a large family of molecular chaperones and have cooperative functions with Hsp70. Most of the J-proteins contain a “J” domain through which they can interact with and stimulate Hsp70. Based on the structural differences, J-proteins can be classified into four types, that is, Type I, Type II, Type III, and Type IV J-proteins. Type I J-proteins contain an N-terminal J-domain that is separated from the rest of the proteins by a linker “G/F” region (glycine/phenylalanine region) [3, 4]. Distal to G/F region is the zinc-binding cysteine-rich sequence named as “Zinc-finger domain” which distinguishes Type I proteins from other types of J-proteins [4], and Zinc-finger domain is followed by the C-terminal domain [1, 2]. Type II proteins possess all the domains in Type I except the zinc-finger domain [3]. Type III J-proteins contain a C-terminal J-domain but lack both G/F and zinc-finger domains [3]. Type IV, also known as the J-like protein [5], is a group of recently identified proteins that lacks histidine, proline, and aspartate signature motifs in their sequences [4].

By binding Hsp70 and Hsp90, J-proteins play important roles in chaperone cycle regulation and control many physiological functions [4], such as assisting the folding of nascent and damaged proteins, translocation of polypeptides across cellular membranes, and degradation of misfolded proteins [6]. Studies carried out in the past decade have also shown the regulatory roles of J-proteins in cell death. In association with Hsp70, J-proteins not only involve in the folding of caspase-activated DNase which is responsible for the apoptosis-induced DNA fragmentation [7] but also protect the macrophages from nitric-oxide-mediated apoptosis [8]. Gotoh and his colleagues have demonstrated the role of J-protein in the inhibition of Bax translocation to the mitochondria to prevent nitric-oxide-induced cell apoptosis [9]. Kurisu et al. found that MDG1/ERdj4, a member of the human J-protein family, can interact with GRP78/BiP and protect against the cell death induced by endoplasmic reticulum stress in human [10]. The regulation of cell death by J-protein was also reported in plant. Liu and Whitham found that the overexpression of J-protein stimulated the hypersensitive response (HR)-like cell death in soybean [11]. Cancer progressions are also reported to be closely related to J-proteins, but different types of J-proteins play distinct roles [12, 13]. Type I J-protein is tumour promoting, while Type II J-protein acts as tumour suppressors [13]. Therefore, reliably annotating the types of J-proteins is of major importance in order to clarify their distinct biological functions in cell death. However, to the best of our knowledge, there is no computational method for predicting the types of J-proteins.

Keeping these in mind, in the present work, we proposed a model to predict the four functional types of J-proteins based on reduced amino acid alphabet compositions. According to a recent review [14], the rest of the papers are organized as follows: (i) construct a valid benchmark dataset to train and test the predictor; (ii) formulate the samples with an effective mathematical expression that can truly reflect their intrinsic correlation with the target to be predicted; (iii) select a powerful machine learning method to operate the prediction; (iv) perform cross-validation tests to objectively evaluate the anticipated accuracy of the predictor; (v) provide a web server for the prediction method.

2. Materials and Methods

2.1. Dataset

The sequences of J-protein were taken from the HSPIR database at, which currently contains 3,901 J-protein sequences [15]. To reduce homologous bias, J-proteins that have ≥40% pairwise sequence identity to each other were removed by using the CD-HIT program [16]. By doing so, we obtained a benchmark dataset containing 1,245 J-proteins that were classified into four types: 63 Type I J-proteins, 53 Type II J-proteins, 1,107 Type III J-proteins, and 22 Type IV J-proteins (Table 1). The benchmark dataset can be freely downloaded from

Total numberSubfamilyNumber

1245Type I J-protein63
Type II J-protein53
Type III J-protein1107
Type IV J-protein22

2.2. Reduced Amino Acid Alphabet

Based on the physiochemical properties, the 20 native amino acids can be clustered into a smaller number of representative residues called reduced amino acid alphabet (RAAA) [1719]. Compared with the traditional amino acid composition, RAAA not only simplifies the complexity of protein system but also improves the ability in finding structurally conserved regions and structural similarity of entire proteins.

Recently, a structural alphabet called protein blocks (PBs) was proposed by de Brevern et al. [20, 21] and has been widely used in computational proteomics as indicated in a review [22]. To aid the design of mutations, Etchebest and his colleagues defined a novel type of RAAA based on PBs [23], where the 20 native amino acids can form five different cluster profiles, that is, CP(13), CP(11), CP(9), CP(8), and CP(5) as shown in Table 2. Ever since it was proposed, RAAA has been widely used for protein family classifications [2427].

Cluster profilesProtein blocks method


Hence, in the present study, the J-proteins were encoded using the RAAA as formulated by the discrete feature vector P: where T is the transposing operator and is the occurrence frequency of the th -peptide RAAA and defined as where is the number of the th-peptide (, 2, or 3) RAAA in a J-protein with length of . For the different cluster profiles (Table 2) and different values of , the vector dimension () in (1) will be different. The corresponding dimensions of reduced amino acid () composition, reduced dipeptide () composition, and reduced tripeptide () composition were listed in Table 3.

-peptideCluster profiles


2.3. Support Vector Machine (SVM)

SVM is a powerful and popular method for pattern recognition that has been widely used in the realm of bioinformatics [2841]. The basic idea of SVM is to transform the data into a high dimensional feature space and then determine the optimal separating hyperplane using a kernel function. To handle a multiclass problem, “one-versus-one (OVO)” and “one-versus-rest (OVR)” methods are generally applied to extend the traditional SVM. For a brief formulation of SVM and how it works, see the papers [28, 29].

In the current study, the LIBSVM 2.84 package [42] was used as an implementation of SVM, which can be downloaded from The OVO method was employed for making predictions using the popular radial basis function (RBF). The regularization parameter and the kernel width parameter were determined via an optimization procedure using a grid search approach using the fivefold cross-validation. In grid research, the search spaces for parameter and range from 215 to and from to with the steps of and 2, respectively.

2.4. Performance Evaluation

The performance of the method was measured in terms of sensitivity (Sn), specificity (Sp), Matthew’s correlation coefficient (MCC), and overall accuracy (OA) defined as follows:where , , , and represent true positive, true negative, false positive, and false negative of family ; is the number of subsets and equals to 4, while is the number of the total J-proteins in benchmark dataset.

3. Results and Discussion

3.1. Cross-Validation

Three cross-validation methods, namely, subsampling (or K-fold cross-validation) test, independent dataset test, and jackknife test, are often used to evaluate the quality of a predictor [43]. Among the three methods, the jackknife test is deemed the least arbitrary and most objective as elucidated in [44] and hence has been widely recognized and increasingly adopted by investigators to examine the quality of various predictors [31, 34, 4550]. Accordingly, the jackknife test was used to examine the performance of the model proposed in the current study. In the jackknife test, each sequence in the training dataset is in turn singled out as an independent test sample and all the rule parameters are calculated without including the one being identified.

The jackknife results obtained by the proposed model on the benchmark dataset based on the five different cluster profiles of the tripeptide (i.e., ) case were listed in Table 4. As it can be seen from Table 4, the best success rate of 94.06% was achieved when the predictions were based on CP(8) with a dimension of 512. For comparison, the results of the amino acid (i.e., ) and dipeptide (i.e., ) cases were also calculated and listed in Table 5, from which we can see that none of them has higher success rates than the case of .

SubfamilyMetricsFeature dimension of for each cluster profile

Type I J-proteinSn63.49%74.60%77.78%74.60%60.31%
Type II J-proteinSn37.73%45.28%39.62%49.06%24.53%
Type III J-proteinSn99.81%98.82%99.09%98.56%99.19%
Type IV J-proteinSn027.27%13.64%31.81%4.54%


(a) For the single amino acid case

SubfamilyMetricsFeature dimension of for each cluster profile

Type I J-proteinSn71.42%65.08%68.25%52.38%50.79%22.22%
Type II J-proteinSn33.96%30.19%33.96%16.98%16.98%15.09%
Type III J-proteinSn98.74%98.28%98.10%99.09%98.73%98.19%
Type IV J-proteinSn4.54%00000


(b) For the dipeptide case

SubfamilyMetricsFeature dimension of for each cluster profile

Type I J-proteinSn74.42%60.31%73.02%60.32%58.73%49.20%
Type II J-proteinSn39.76%45.23%39.62%39.62%35.84%28.30%
Type III J-proteinSn98.88%98.10%98.82%97.74%98.01%97.31%
Type IV J-proteinSn13.16%27.27%022.73%25.00%9.09%


In our previous study [27], the six HSP families were successfully classified by using the dipeptide of RAAA. But for the classification of the J-protein subfamilies in the present work, the best predictive result was obtained by using the tripeptide of RAAA. Hsps belong to the same family share more sequence identity than that of different families [5]; hence we need more suitable parameters to encode the protein sequences as used in the current study.

3.2. Comparison with Other Methods

Since there is no published work to predict the types of J-proteins, we could not provide the comparison analysis with existing results to confirm that our presented model is superior to other methods. However, for the purpose of comparison, we compared the results of the present model with that of Random Forest and Naïve Bayes using the same optimal features (the reduced tripeptide compositions based on CP(8)). The results of jackknife test on the benchmark dataset for Random Forest and Naïve Bayes are listed in Table 6. It is shown that the accuracy of SVM is higher than that of Random Forest and Naïve Bayes.

SubfamilySVMRandom ForestNaïve Bayes

Type I J-protein74.60%98.76%0.7514.29%99.55%0.2974.60%92.17%0.47
Type II J-protein49.06%99.05%0.5713.33%99.82%0.3154.72%94.67%0.39
Type III J-protein98.56%62.02%0.6999.73%12.70%0.3188.62%65.83%0.43
Type IV J-protein31.81%100.00%0.564.55%100.00%0.2113.64%100.00%0.37


3.3. Amino Acids Composition Analysis

To provide an overall view, the frequencies of the 20 naive amino acids were compared among the four types of J-proteins using the analysis of variance (ANOVA), and the average amino acid frequency of one type of J-protein with that of another type was further explored and compared using the Fisher’s least significant difference (LSD) test. The result is given in Figure 1, where the green boxes indicate that the frequency differences among different types of J-proteins are not significant, while blue and red boxes indicate that the frequency differences are significant (; LSD test) among different types of J-proteins (see Figure 1 for more details).

We found that, except Asn (N), the frequencies of all the other 19 amino acids are significantly different among the four types of J-proteins. Compared with other three types, Type I J-proteins are enriched in Cys (C), Gly (G), and Thr (T), Type II J-proteins are enriched in Phe (F), Type III J-proteins are enriched in Ala (A) and Leu (L), while Type IV-J proteins are enriched in Met (M), Gln (Q), Glu (E), and Pro (P) but lack Asp (D) and His (H). The lack of D and H residues in Type IV-J proteins leads to their inability to stimulate ATP hydrolysis [5]. Moreover, according to the binomial distribution [51], we also found the overpresented tripeptides in each family and listed them in Supporting Table S1 in Supplementary Material available online at, where the over-presented tripeptides with their confidence levels are provided. These results indicate that the distinct distributions of amino acids in the four types of J-proteins may account for their distinct functions in biological processes.

3.4. Web Server Guide

To enhance the value of the practical applications of the proposed model and for the convenience of the vast majority of experimental scientists, an online predictor was developed. The step-by-step guide on how to use it is provided as follows.(1)Open the web server at and you will see the top page as shown in Figure 2. Click on the Read Me button to see a brief introduction about the predictor and the caveat when using it, and click on the Data button to download the benchmark datasets used to train and test the predictor. The relevant papers that document the algorithm of the predictor can be found by clicking on the Citation button.(2)Either type or copy/paste the query J-protein sequence into the input box at the center of Figure 2. The input protein sequence should be in the FASTA format that can be seen by clicking on the Example button right above the input box.(3)Click on the Submit button to see the predicted result. For example, if you use the four query J-protein sequences in the Example window as the input, after clicking the Submit button, you will obtain the results: the outcome for the 1st query sample is “Type I J-protein;” the outcome for the 2nd query sample is “Type II J-protein;” the outcome for the 3rd query sample is “Type III J-protein;” the outcome for the 4th query sample is “Type IV J-protein.”

4. Conclusion

Cell death is a common phenomenon in developmental processes or in normal physiological conditions and is induced by an array of extra- or intracellular stimuli [7]. However, organisms are equipped with their own physiological defense to cope with environmental stress in order to prevent or induce cell death depending upon the severity of the stress [7]. In mammalian cells, the stress response involves the induction of Hsps, such as Hsp70 and Hsp90. By interacting with J-proteins, these Hsps play pivotal roles in cell death regulations. Since J-proteins act as intermediates, the analysis of J-proteins functions is urgent in order to clarify the regulatory roles of Hsps in cell death.

Based on combination of whole-genome analyses and biochemical evidences, a large number of J-proteins have been identified [6]. However, the exact roles for many of the J-proteins are far from being understood [2, 52]. In order to understand its biological functions, it is highly desirable to know which family a given J-protein belongs to.

By encoding the sequences using the reduced amino acid alphabet information, a predictor was developed to identify the four different families of J-proteins in the present work. To enhance the value of the practical applications of the proposed model and for the convenience of the experimental scientists, an online web server was provided and can be freely accessed at We hope that the present model will be helpful for scientists who focus on J-proteins and will provide novel insights into the research of cell death.

Conflict of Interests

There is no conflict of interests with any financial organization regarding this paper.


The authors wish to express their gratitude to executive editor and three anonymous reviewers whose constructive comments were very helpful in strengthening the presentation of this paper. This work was supported by the National Nature Scientific Foundation of China (nos. 61100092 and 61202256), Nature Scientific Foundation of Hebei Province (no. C2013209105), Foundation of Science and Technology Department of Hebei Province (no. 132777133), and the Fundamental Research Funds for the Central Universities (ZYGX2013J102).

Supplementary Materials

According to the binomial distribution, we analyzed the distribution of the tripeptides and found the over-presented tripeptides in each J-protein families. Listed in Supporting Table S1 are the over-presented tripeptides with confidence level (=1-p) greater than 99.9%.

  1. Supplementary Table


  1. A. J. Caplan, D. M. Cyr, and M. G. Douglas, “Eukaryotic homologues of Escherichia coli dnaJ: a diverse protein family that functions with HSP70 stress proteins,” Molecular and Cellular Biology, vol. 4, no. 6, pp. 555–563, 1993. View at: Google Scholar
  2. X. B. Qiu, Y. M. Shao, S. Miao, and L. Wang, “The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperones,” Cellular and Molecular Life Sciences, vol. 63, no. 22, pp. 2560–2570, 2006. View at: Publisher Site | Google Scholar
  3. M. E. Cheetham and A. J. Caplan, “Structure, function and evolution of DnaJ: conservation and adaptation of chaperone function,” Cell Stress Chaperones, vol. 3, no. 1, pp. 28–36, 1998. View at: Google Scholar
  4. V. B. Rajan and P. D'Silva, “Arabidopsis thaliana J-class heat shock proteins: cellular stress sensors,” Functional & Integrative Genomics, vol. 9, no. 4, pp. 433–446, 2009. View at: Publisher Site | Google Scholar
  5. P. Walsh, D. Bursać, Y. C. Law, D. Cyr, and T. Lithgow, “The J-protein family: modulating protein assembly, disassembly and translocation,” EMBO Reports, vol. 5, no. 6, pp. 567–571, 2004. View at: Publisher Site | Google Scholar
  6. E. A. Craig, P. Huang, R. Aron, and A. Andrew, “The diverse roles of J-proteins, the obligate Hsp70 co-chaperone,” Reviews of Physiology, Biochemistry and Pharmacology, vol. 156, pp. 1–21, 2006. View at: Publisher Site | Google Scholar
  7. A. S. Sreedhar and P. Csermely, “Heat shock proteins in the regulation of apoptosis: new strategies in tumor therapy—a comprehensive review,” Pharmacology & Therapeutics, vol. 101, no. 3, pp. 227–257, 2004. View at: Publisher Site | Google Scholar
  8. T. Gotoh, K. Terada, and M. Mori, “Hsp70-DnaJ chaperone pairs prevent nitric oxide-mediated apoptosis in RAW 264.7 macrophages,” Cell Death & Differentiation, vol. 8, no. 4, pp. 357–366, 2001. View at: Publisher Site | Google Scholar
  9. T. Gotoh, K. Terada, S. Oyadomari, and M. Mori, “hsp70-DnaJ chaperone pair prevents nitric oxide- and CHOP-induced apoptosis by inhibiting translocation of Bax to mitochondria,” Cell Death & Differentiation, vol. 11, no. 4, pp. 390–402, 2004. View at: Publisher Site | Google Scholar
  10. J. Kurisu, A. Honma, H. Miyajima, S. Kondo, M. Okumura, and K. Imaizumi, “MDG1/ERdj4, an ER-resident DnaJ family member, suppresses cell death induced by ER stress,” Genes to Cells, vol. 8, no. 2, pp. 189–192, 2003. View at: Publisher Site | Google Scholar
  11. J. Z. Liu and S. A. Whitham, “Overexpression of a soybean nuclear localized type-III DnaJ domain -containing HSP40 reveals its roles in cell death and disease resistance,” Plant Journal, vol. 74, no. 1, pp. 110–121, 2013. View at: Publisher Site | Google Scholar
  12. A. Mitra, L. A. Shevde, and R. S. Samant, “Multi-faceted role of HSP40 in cancer,” Clinical & Experimental Metastasis, vol. 26, no. 6, pp. 559–567, 2009. View at: Publisher Site | Google Scholar
  13. J. N. Sterrenberg, G. L. Blatch, and A. L. Edkins, “Human DNAJ in cancer and stem cells,” Cancer Letters, vol. 312, no. 2, pp. 129–142, 2011. View at: Publisher Site | Google Scholar
  14. K.-C. Chou, “Some remarks on protein attribute prediction and pseudo amino acid composition,” Journal of Theoretical Biology, vol. 273, no. 1, pp. 236–247, 2011. View at: Publisher Site | Google Scholar
  15. R. K. Ratheesh, S. N. Nagarajan, P. A. Arunraj et al., “HSPIR: a manually annotated heat shock protein information resource,” Bioinformatics, vol. 28, no. 21, pp. 2853–2855, 2012. View at: Google Scholar
  16. W. Li and A. Godzik, “Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences,” Bioinformatics, vol. 22, no. 13, pp. 1658–1659, 2006. View at: Publisher Site | Google Scholar
  17. P. D. Thomas and K. A. Dill, “An iterative method for extracting energy-like quantities from protein structures,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 21, pp. 11628–11633, 1996. View at: Publisher Site | Google Scholar
  18. L. A. Mirny and E. I. Shakhnovich, “Universally conserved positions in protein folds: reading evolutionary signals about stability, folding kinetics and function,” Journal of Molecular Biology, vol. 291, no. 1, pp. 177–196, 1999. View at: Publisher Site | Google Scholar
  19. A. D. Solis and S. Rackovsky, “Optimized representations and maximal information in proteins,” Proteins, vol. 38, no. 2, pp. 49–164, 2000. View at: Google Scholar
  20. A. G. de Brevern, “New assessment of a structural alphabet,” In Silico Biology, vol. 5, no. 3, pp. 283–289, 2005. View at: Google Scholar
  21. A. G. de Brevern, C. Etchebest, and S. Hazout, “Bayesian probabilistic approach for predicting backbone structures in terms of protein blocks,” Proteins, vol. 41, no. 3, pp. 271–287, 2000. View at: Google Scholar
  22. A. P. Joseph, G. Agarwal, S. Mahajan et al., “A short survey on protein blocks,” Biophysical Reviews, vol. 2, no. 3, pp. 137–147, 2010. View at: Publisher Site | Google Scholar
  23. C. Etchebest, C. Benros, A. Bornot, A.-C. Camproux, and A. G. de Brevern, “A reduced amino acid alphabet for understanding and designing protein adaptation to mutation,” European Biophysics Journal, vol. 36, no. 8, pp. 1059–1069, 2007. View at: Publisher Site | Google Scholar
  24. Y. C. Zuo and Q. Z. Li, “Using reduced amino acid composition to predict defensin family and subfamily: Integrating similarity measure and structural alphabet,” Peptides, vol. 30, no. 10, pp. 1788–1793, 2009. View at: Publisher Site | Google Scholar
  25. W. Chen, P. M. Feng, and H. Lin, “Prediction of ketoacyl synthase family using reduced amino acid alphabets,” Journal of Industrial Microbiology and Biotechnology, vol. 39, no. 4, pp. 579–584, 2011. View at: Publisher Site | Google Scholar
  26. Y. L. Chen, Q. Z. Li, and L. Q. Zhang, “Using increment of diversity to predict mitochondrial proteins of malaria parasite: integrating pseudo-amino acid composition and structural alphabet,” Amino Acids, vol. 42, no. 4, pp. 1309–1316, 2010. View at: Publisher Site | Google Scholar
  27. P. M. Feng, W. Chen, H. Lin, and K. C. Chou, “iHSP-PseRAAAC: identifying the heat shock protein families using pseudo reduced amino acid alphabet composition,” Analytical Biochemistry, vol. 442, no. 1, pp. 118–125, 2013. View at: Publisher Site | Google Scholar
  28. K. C. Chou and Y. D. Cai, “Using functional domain composition and support vector machines for prediction of protein subcellular location,” The Journal of Biological Chemistry, vol. 277, no. 48, pp. 45765–45769, 2002. View at: Publisher Site | Google Scholar
  29. Y. D. Cai, G. P. Zhou, and K. C. Chou, “Support vector machines for predicting membrane protein types by using functional domain composition,” Biophysical Journal, vol. 84, no. 5, pp. 3257–3263, 2003. View at: Google Scholar
  30. W. Chen and H. Lin, “Prediction of midbody, centrosome and kinetochore proteins based on gene ontology information,” Biochemical and Biophysical Research Communications, vol. 401, no. 3, pp. 382–384, 2010. View at: Publisher Site | Google Scholar
  31. M. Hayat and A. Khan, “MemHyb: predicting membrane protein types by hybridizing SAAC and PSSM,” Journal of Theoretical Biology, vol. 292, pp. 93–102, 2012. View at: Publisher Site | Google Scholar
  32. H. Lin and H. Ding, “Predicting ion channels and their types by the dipeptide mode of pseudo amino acid composition,” Journal of Theoretical Biology, vol. 269, no. 1, pp. 64–69, 2011. View at: Publisher Site | Google Scholar
  33. X. Xiao, P. Wang, and K.-C. Chou, “iNR-physchem: a sequence-based predictor for identifying nuclear receptors and their subfamilies via physical-chemical property matrix,” PLoS ONE, vol. 7, no. 2, Article ID e30869, 2012. View at: Publisher Site | Google Scholar
  34. W. Chen, P. M. Feng, H. Lin, and K. C. Chou, “iRSpot-PseDNC: identify recombination spots with pseudo dinucleotide composition,” Nucleic Acids Research, vol. 41, no. 6, p. e68, 2013. View at: Publisher Site | Google Scholar
  35. P. M. Feng, H. Lin, and W. Chen, “Identification of antioxidants from sequence information using Naive Bayes,” Computational and Mathematical Methods in Medicine, vol. 2013, Article ID 567529, 5 pages, 2013. View at: Publisher Site | Google Scholar
  36. B. Liu, X. Wang, Q. Zou, Q. Dong, and Q. Chen, “Protein remote homology detection by combining chou's pseudo amino acid composition and profile-based protein representation,” Molecular Informatics, vol. 32, no. 9-10, pp. 775–782, 2013. View at: Publisher Site | Google Scholar
  37. B. Liu, X. Wang, Q. Chen, Q. Dong, and X. Lan, “Using amino acid physicochemical distance transformation for fast protein remote homology detection,” PLoS ONE, vol. 7, no. 9, Article ID e46633, 2012. View at: Google Scholar
  38. P. M. Feng, H. Ding, W. Chen, and H. Lin, “Naive Bayes classifier with feature selection to identify phage virion proteins,” Computational and Mathematical Methods in Medicine, vol. 2013, Article ID 530696, 6 pages, 2013. View at: Publisher Site | Google Scholar
  39. B. Liu, X. Wang, L. Lin, B. Tang, Q. Dong, and X. Wang, “Prediction of protein binding sites in protein structures using hidden Markov support vector machine,” BMC Bioinformatics, vol. 10, article 381, 2009. View at: Publisher Site | Google Scholar
  40. B. Liu, X. Wang, L. Lin, Q. Dong, and X. Wang, “Exploiting three kinds of interface propensities to identify protein binding sites,” Computational Biology and Chemistry, vol. 33, no. 4, pp. 303–311, 2009. View at: Publisher Site | Google Scholar
  41. B. Liu, X. Wang, L. Lin, Q. Dong, and X. Wang, “A discriminative method for protein remote homology detection and fold recognition combining Top-n-grams and latent semantic analysis,” BMC Bioinformatics, vol. 9, article 510, 2008. View at: Publisher Site | Google Scholar
  42. C. C. Chang and C. J. Lin, “LIBSVM: a library for support vector machines,” 2001, View at: Google Scholar
  43. K. C. Chou and C. T. Zhang, “Prediction of protein structural classes,” Critical Reviews in Biochemistry and Molecular Biology, vol. 30, no. 4, pp. 275–349, 1995. View at: Google Scholar
  44. K. C. Chou and H. B. Shen, “Cell-PLoc: a package of Web servers for predicting subcellular localization of proteins in various organisms,” Nature Protocols, vol. 3, no. 2, pp. 153–162, 2008. View at: Publisher Site | Google Scholar
  45. M. Esmaeili, H. Mohabatkar, and S. Mohsenzadeh, “Using the concept of Chou's pseudo amino acid composition for risk type prediction of human papillomaviruses,” Journal of Theoretical Biology, vol. 263, no. 2, pp. 203–209, 2010. View at: Publisher Site | Google Scholar
  46. S. Mei, “Predicting plant protein subcellular multi-localization by Chou's PseAAC formulation based multi-label homolog knowledge transfer learning,” Journal of Theoretical Biology, vol. 310, pp. 80–87, 2012. View at: Publisher Site | Google Scholar
  47. K. C. Chou, Z. C. Wu, and X. Xiao, “iLoc-Euk: a multi-label classifier for predicting the subcellular localization of singleplex and multiplex eukaryotic proteins,” PLoS ONE, vol. 6, no. 3, Article ID e18258, 2011. View at: Publisher Site | Google Scholar
  48. H. Mohabatkar, “Prediction of cyclin proteins using Chou's pseudo amino acid composition,” Protein and Peptide Letters, vol. 17, no. 10, pp. 1207–1214, 2010. View at: Publisher Site | Google Scholar
  49. K. C. Chou, Z. C. Wu, and X. Xiao, “ILoc-Hum: using the accumulation-label scale to predict subcellular locations of human proteins with both single and multiple sites,” Molecular BioSystems, vol. 8, no. 2, pp. 629–641, 2012. View at: Publisher Site | Google Scholar
  50. H. Mohabatkar, M. Mohammad Beigi, and A. Esmaeili, “Prediction of GABAA receptor proteins using the concept of Chou's pseudo-amino acid composition and support vector machine,” Journal of Theoretical Biology, vol. 281, no. 1, pp. 18–23, 2011. View at: Publisher Site | Google Scholar
  51. C. Ding, L. F. Yuan, S. H. Guo, H. Lin, and W. Chen, “Identification of mycobacterial membrane proteins and their types using over-represented tripeptide compositions,” Journal of Protemics, vol. 77, pp. 321–328, 2012. View at: Google Scholar
  52. K. Ohtsuka and M. Hata, “Mammalian HSP40/DNAJ homologs: cloning of novel cDNAs and a proposal for their classification and nomenclature,” Cell Stress and Chaperones, vol. 5, no. 2, pp. 98–112, 2000. View at: Google Scholar

Copyright © 2014 Pengmian Feng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1357 Views | 517 Downloads | 23 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.